Published in Biochem Biophys Res Commun on July 29, 1983
Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest (1984) 2.41
Senile systemic amyloidosis. Am J Pathol (1984) 1.69
A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet (1990) 1.39
Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest (1986) 1.38
Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J Exp Med (1986) 1.28
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest (1986) 1.23
Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet (1994) 1.10
Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. J Clin Invest (1985) 1.04
Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest (1988) 0.97
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest (1990) 0.91
Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest (1994) 0.91
Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs. J Clin Invest (1987) 0.86
Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy before clinical onset. J Clin Invest (1986) 0.84
Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I. J Clin Invest (1985) 0.84
Frequency and genetic background of the position 122 (Val----Ile) variant transthyretin gene in the black population. Am J Hum Genet (1991) 0.84
Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut (1994) 0.81
A DNA test for Indiana/Swiss hereditary amyloidosis (FAP II). Am J Hum Genet (1988) 0.80
Leptomeningeal amyloid and variant transthyretins. Am J Pathol (1996) 0.79
Prealbumin: its association with amyloid. J Clin Pathol (1987) 0.78
A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathy. J Med Genet (1995) 0.76
Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy. Am J Pathol (1992) 0.76
Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin. J Neurol Neurosurg Psychiatry (1988) 0.76
A transthyretin variant (alanine 49) associated with familial amyloidotic polyneuropathy in a French family. J Med Genet (1993) 0.75
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science (1991) 4.09
MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem (2000) 2.83
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem (1998) 2.26
Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics (1989) 2.17
Familial amyloidotic polyneuropathy. Trends Neurosci (1989) 1.89
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics (1990) 1.74
Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci U S A (1984) 1.74
Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science (1989) 1.69
The protofilament substructure of amyloid fibrils. J Mol Biol (2000) 1.69
C-reactive protein and the acute-phase response. J Lab Clin Med (1981) 1.67
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum (1979) 1.53
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography. Arthritis Rheum (1975) 1.46
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest (1977) 1.45
Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis. Arthritis Rheum (1989) 1.45
Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol (1980) 1.44
The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. J Biol Chem (1993) 1.42
Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest (1981) 1.41
Amyloidosis of the shoulder in patients on chronic hemodialysis: sonographic findings. AJR Am J Roentgenol (1996) 1.41
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest (1986) 1.38
Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest (1977) 1.35
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun (1988) 1.35
Transthyretin: a review from a structural perspective. Cell Mol Life Sci (2001) 1.34
Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun (1985) 1.32
Treatment of Wegener's granulomatosis with immunosuppressive agents. Description of renal ultrastructure. Arch Intern Med (1970) 1.29
Internal duplication and evolution of human ceruloplasmin. Proc Natl Acad Sci U S A (1981) 1.25
Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum (1983) 1.23
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest (1986) 1.23
Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem (1989) 1.21
Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med (1975) 1.21
Internal triplication in the structure of human ceruloplasmin. Proc Natl Acad Sci U S A (1983) 1.15
Purification and characterization of undegraded human ceruloplasmin. Anal Biochem (1980) 1.14
Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis (1980) 1.14
Antigenic determinants in amyloid deposits. Nature (1970) 1.13
Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med (1977) 1.11
Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol (1991) 1.10
Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology (1996) 1.10
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res (1992) 1.08
Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin. Proc Natl Acad Sci U S A (1981) 1.08
Fibrillar assemblage of variable segments of immunoglobulin light chains: an electron microscopic study. J Immunol (1973) 1.08
Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol (1979) 1.08
Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy. J Neuropathol Exp Neurol (2000) 1.08
A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis. Biochem Biophys Res Commun (1999) 1.08
Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol (2001) 1.07
A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J Med Genet (1992) 1.07
DMSO and colchicine therapy in amyloid disease. Ann Rheum Dis (1984) 1.07
Neuropathy, M components, and amyloid. Lancet (1975) 1.07
DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem Genet (1986) 1.06
Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody. Ann Intern Med (1970) 1.05
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol (1999) 1.05
Amyloidosis related to a lambda IV immunoglobulin light chain protein. Scand J Immunol (1989) 1.03
Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation. Proc Natl Acad Sci U S A (1995) 1.03
P-component of amyloid. Isolation from human serum by affinity chromatography. Arthritis Rheum (1976) 1.02
Cerebrovascular biomodelling: a technical note. Surg Neurol (1999) 1.01
Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta (1995) 1.01
Serum amyloid protein levels in south american children with rheumatoid arthritis: a co-operative study. Ann Rheum Dis (1980) 1.01
Development and characterization of a collagen degradation assay to assess purified collagenase used in islet isolation. Transplant Proc (2008) 1.01
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med (1991) 1.00
Tissue dissociation enzyme neutral protease assessment. Transplant Proc (2010) 1.00
Adult survival with intrahepatic portal venous gas secondary to acute gastric dilatation, with a review of portal venous gas. Clin Radiol (1985) 0.99
Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid. Arthritis Rheum (1987) 0.99
Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis. Amyloid (2001) 0.99
SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol (1982) 0.98
Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry (1988) 0.98
Hereditary amyloidosis: detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet (1990) 0.98
Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta (1994) 0.97
Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest (1988) 0.97
Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person. J Clin Invest (1988) 0.97
Amyloid deposition in a renal transplant in familial Mediterranean fever. Ann Intern Med (1977) 0.97
Polymorphism in a kappa I primary (AL) amyloid protein (BAN). Mol Immunol (1986) 0.96
Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain. Biochim Biophys Acta (1999) 0.94
A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol (1999) 0.93
Amino acid sequence of a kappa I primary (AL) amyloid protein (AND). Mol Immunol (1990) 0.93
Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol (1999) 0.93
Cerebellar calcification and lead. J Neurol Neurosurg Psychiatry (1985) 0.93
Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation. Amyloid (1998) 0.93
In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand J Immunol (1995) 0.93
Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants. J Clin Endocrinol Metab (1993) 0.92
A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis. Blood (1996) 0.92
Amyloid fibril protein related to immunoglobulin lambda-chains. J Immunol (1975) 0.92
Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology (2003) 0.92
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest (1990) 0.91
Amino acid sequence of a lambda VI primary (AL) amyloid protein (WLT). Scand J Immunol (1985) 0.91
Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy. Int J Lepr Other Mycobact Dis (1979) 0.91
Stepwise sequence determination from the carboxyl terminus of peptides. Biochemistry (1982) 0.91
The Ile-84-->Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein. J Biol Chem (1994) 0.91
Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Arthritis Rheum (1986) 0.91